Honda will recall more than 245,000 vehicles in China over concerns about airbags made by troubled Japanese giant Takata, Chinese authorities said today, dealing another blow to Takata's largest client. The Japanese carmaker and its Chinese joint venture partner Guangqi Honda will start withdrawing vehicles fitted with the potentially faulty airbags beginning October 23 and will include Accord, Fit, City, Crosstour and Everus S1 models, China's top consumer watchdog said. They will replace the faulty airbags for free.
Also Read: Takata's Bankruptcy To Pit Automakers Against Airbag Victims
Takata has recalled some 100 million airbags produced for some of the world's largest automakers, including about 70 million in the US, because of the risk that they could improperly inflate and rupture, potentially firing deadly shrapnel at the vehicle's occupants. The problem has been linked to a number of deaths and injuries worldwide.
In China, the defect involves more than 20 million vehicles, most of which have already been recalled. Last month, Honda reached a USD 605 million settlement in a lawsuit over defective airbags in millions of cars on American roads. Honda joins Nissan, Toyota, BMW, Mazda and Subaru in agreeing a deal to settle a lawsuit, replace the defective airbags from now-bankrupt Takata, and to compensate car owners.
Also Read: Takata Bankruptcy Would Cloud Auto Industry's Biggest Recall
Multiple Honda models are affected by the case, including Civic, Accord and CR-V, dating back to 2001. The airbag defect has been linked to 16 deaths and scores of injuries worldwide, as the safety devices can inflate with excessive force, sending shrapnel from the inflator canister hurtling towards driver and passengers. The issue led to the biggest car recall in history of about 100 million vehicles worldwide.
Takata in February pleaded guilty to fraud for hiding the defect, and paid a USD 1 billion fine. The company filed for bankruptcy in June. The bankruptcy could mean the major automakers may find the airbag producer will not reimburse them for their costs, despite an USD 875 million fund created by Takata in January.
